Lilly Plans to Add $180 Million Insulin Manufacturing Investment

Eli Lilly expects to invest an additional $180 million in the company's Indianapolis-based insulin manufacturing operations.

Sarepta Picks Up $25M Manufacturing Plant in Massachusetts

Sarepta Therapeutics is acquiring a facility in Massachusetts to manufacture investigational exon-skipping therapies for Duchenne muscular dystrophy (DMD).

Westburg to Supply Denator’s Stabilizor System in Benelux Region

Product uses heat-inactivation technology and preserves components in their in vivo state.

GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66...

Potentially €4 million agreement will lead to production of clinical trials material for GeoVax at Vivalis’ facility.

New UMass Accelerator to Focus on Growing Biomanufacturing

The University of Massachusetts (UMass) Dartmouth will break ground this week on a $28 million business accelerator in Fall River, MA, that is intended to advance the biomanufacturing segment of the state’s growing life...

Lonza Expands Presence in China with GE Healthcare

Lonza has expanded its presence in China by signing a deal under which GE Healthcare will deliver a KUBio off-the-shelf biologics facility to Lonza in Guangzhou.

Patheon to Manufacture Pharmalink’s IgA Nephropathy Product

Swedish specialty pharma firm Pharmalink has contracted Patheon to provide development and manufacturing services for its lead clinical-stage product, Nefecon® (PL-56), which is in development to address the pathology of IgA nephropathy, the most...

AveXis to Acquire AstraZeneca Manufacturing Site in Longmont, CO

Novartis subsidiary AveXis plans to expand its gene therapy manufacturing capacity by agreeing to purchase AstraZeneca’s advanced biologics therapy manufacturing campus in Longmont, CO, for an undisclosed price. AstraZeneca in January disclosed plans to close the...

Pfenex Scores Government Contract to Develop Production Process for Bulk Recombinant Protective Antigen from...

BARDA funding could total $18.8 million if all milestones are met and options and extensions are made.

Bavarian Nordic Wins Up-to-$33M Janssen Subcontract for Ebola Vaccine Regimen

Award focused on manufacturing and storage of the companies’ Ebola prime-boost vaccine regimen candidate.

Recently Featured

Stay Connected

Scroll Up